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Abstract
Objective—To investigate changes in depressive symptoms in hypertensive individuals
participating in an exercise and weight loss intervention.
Methods—133 sedentary men and women with high blood pressure (130–180 mmHg SBP and/or
85–110 mmHg DBP) who participated in a 6 month intervention consisting of three groups: aerobic
exercise, aerobic exercise and weight loss, and a waiting list control.
Results—Participants in both treatment groups demonstrated significant improvements in aerobic
capacity and lower BP compared with participants in the control group. Participants in the active
treatment groups who had mild to moderate depressive symptoms at baseline also exhibited greater
reductions in depressive symptoms compared to participants in the control group. Conclusion:
Results from the present study suggest that an exercise, alone or combined with weight management,
may reduce self-reported depressive symptoms among patients with hypertension.
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Depression is a major health burden worldwide and is relatively common among individuals
with chronic health conditions [1–3]. Although there have been important advances in
pharmacological treatment of depression [4], a significant number of patients do not respond
to antindepressant medication [5]. Consequently, there has been considerable interest in the
development of new and effective treatments for depression. A growing body of research
indicates that exercise may be a safe and effective treatment for depression [6–8] comparable
to psychotherapy [9,10] and pharmacologic treatment [11,12]. The majority of previous studies
have found exercise to be effective in reducing depressive symptoms both among healthy
populations [7,13–17] as well as patients with heart disease [18–26]. However, it also has been
noted that many studies have been plagued by methodological weaknesses, such as small
samples, improper statistical analyses, and a lack of a control group, leaving uncertainty about
the value of exercise as a treatment of depression [27].
The present study examines the effects of exercise on depressive symptoms among individuals
with elevated blood pressure (BP). Several previous studies have shown that depression and
hypertension may often exist comorbidly [28,29] and that depression may be a risk factor for
the development of coronary heart disease (CHD) [30,31]. Given the increased risk of CHD
among individuals with depression, interventions that reduce depressive symptoms among
patients with hypertension may be especially important given the increased risk of CHD in this
population. Furthermore, depressive symptoms have been associated with a greater risk for
hypertension-related morbidity, cerebrovascular events, and mortality in hypertensive
individuals, even at subclinical levels [32,33].
Methods
Participants
This study represents a secondary analysis of a previously reported clinical trial examining the
effects of exercise and weight loss in a sample of patients with high blood pressure [34]. Briefly,
participants had unmedicated high normal BP or stage 1 to 2 hypertension and were sedentary,
overweight or obese, and were at least 29 years old. Exclusion criteria included current anti-
depressant use, current substance abuse, medical contraindications to exercise, a major
psychiatric disorder requiring treatment, and ongoing participation in regular aerobic exercise.
Participants were recruited from advertisements placed in local newspapers, television, and
radio stations. Additionally, referrals from local clinics and BP screenings at community health
fairs and local shopping centers contributed to participant recruitment.
As reported previously, 2,399 individuals were initially screened through a preliminary
telephone conversation and 320 individuals underwent a subsequent medical evaluation
(Figure 1). One hundred thirty three individuals met the study criteria and were randomized
following a 2:2:1 schema to one of three groups for the 6-month treatment program: aerobic
exercise (EX; N=54), weight management including aerobic exercise (WM; N=55), and wait
list control (WLC; N=24). All participants who consented to participate in the trial were eligible
for assignment to any one of the three treatment groups.
Interventions
Aerobic Exercise Only participants exercised 3 to 4 times per week at a level of 70% to 85%
of their initial heart rate (HR) reserve [35] determined at the time of their baseline treadmill
test. The exercise program consisted of 10 minutes of warm-up exercises, 35 minutes of cycle
ergometry and walking (and eventually jogging), and 10 minutes of cool-down exercises.
Participants were asked to maintain their pre-treatment diets.
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Weight Management participants exercised 3 to 4 times per week using the identical protocol
as previously described. In addition, participants took part in a weight management program
in small groups of 3 to 4 members based on the LEARN manual [36]. The primary goal of the
intervention was a weight loss of 0.5 to 1.0 kg/wk, achieved gradually by decreasing caloric
consumption and fat intake through lifestyle changes.
The group format consisted of 26 weekly group sessions. Weight was recorded at each session
and participants’ food diaries and behavioral modification targets were reviewed. Group
participation was encouraged during this process in supporting fellow group members and in
problem solving around obstacles and lapses that they may have encountered. During the last
6 weeks of the program, sessions focused increasingly on weight maintenance, and group
members worked on individualized plans for maintaining the changes they had made during
the past 6 months.
Participants in both the EX and WM groups were instructed in how to monitor their radial
pulses and maintain their heart rates (HRs) at, or above, their target level for at least 30 minutes.
A trained exercise physiologist supervised all exercise sessions, and performed 2 to 3 random
checks of HRs per session to ensure that participants were exercising at a sufficient intensity.
Waiting List Control participants were asked to maintain their usual dietary and exercise
habits for 6 months until they were reexamined. On completion of their posttreatment
assessment, participants were then allowed to select either of the 2 active treatments and could
participate under supervision for 6 months.
Depression Measures
In order to investigate the effects of the intervention in alleviating depressive symptoms,
participants completed the Beck Depression Inventory (BDI) [37] at baseline and after 6
months. The BDI is a standardized 21-item self-report questionnaire consisting of symptoms
and attitudes related to depression including items such as self-dislike, suicidal ideation,
insomnia, and sadness. The items are summed with total scores ranging from 0 to 63 with
higher scores indicating higher levels depression. The BDI has been shown to be a valid and
reliable measure of depression severity and a previous meta-analysis have shown the internal
consistency of the BDI to yield a mean coefficient α of .86 for psychiatric patients [38].
Peak Oxygen Consumption
Maximal exercise testing was performed using the Duke-Wake Forest protocol in which graded
exercise began at 3.2 kilometers per hour and 0% grade and workload was increased at a rate
of 1 metabolic equivalent per minute (oxygen, 3.5 mL/kg per minute) [22]. Expired gases were
collected for the determination of peak oxygen consumption using a metabolic cart (model
2900; Sensormedics, Yorba Linda, Calif). Assessments were made at baseline and again
following 6 months of treatment.
Weight and Body Composition Assessment
Weight was measured by a standard balance scale. Body fat measurements were performed
using a bioelectrical impedance analyzer (BIA-101Q; Quantum, Highland Heights, Ohio) in
conjunction with bioelectrical impedance analyzer interpretation software (RJL Systems, Inc,
Clinton Township, Mich). Measurements were done using standard right-sided, tetrapolar
electrode placement with each subject in a supine position. Studies were conducted between
3 and 5pm at ambient temperature following a standard protocol in which participants had
refrained from eating or drinking for at least 3 hours before testing (NIH Technol Assess
Statement, 1994).
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A trained technician obtained BP measurements using a random zero sphygomomanometer,
standardized for cuff size and position. Measurements were made on 4 separate visits during
a 3-week period. At each visit, BP was measured in the nondominant arm in the sitting position
after an initial rest period of 5 minutes. BP was measured 4 successive times at 2-minute
intervals. The first BP measurement of each visit was discarded and the average of the
remaining 3 measurements represented the clinic visit BP. The overall clinic BP was then
determined by averaging the mean BPs over 4 visits. Measurements were obtained in this
standardized manner at baseline and after 6 months.
Data Analysis
Baseline differences among treatment groups were examined using 1-way analysis of variance
(ANOVA) for continuous variables and χ2 tests for categorical variables. Treatment effects
were evaluated using analysis of covariance (ANCOVA), with posttreatment values serving
as the dependent variables and pretreatment values, age, gender, and treatment as the predictors.
Within each model, planned contrasts were used to compare 1) the 2 treatment groups with
controls and 2) WM participants with EX subjects. Separate ANCOVA models were used to
determine the mediating effects of VO2 peak and weight loss in predicting improvement in
depressive symptoms. Following the intent-to-treat principle, participants were analyzed
regardless of adherence to the study protocol.
Results
One hundred thirty three participants were initially randomized for participation (54 in EX, 55
in WM, and 24 in WLC) (Figure 1). Twenty one participants dropped out of the study prior to
completion (10 in EX, 9 in WM, and 2 in WLC), nine of whom returned for follow-up
assessments. Dropouts did not differ from completers in age, gender, or severity of depressive
symptoms, although there was a higher percentage of Caucasian participants among completers
(P < .01). Participants in the EX group had lower SBP compared with their WM counterparts
(SBP = 138.0 vs. 143.6, p = .024). No other group differences were observed for any clinical
or demographic variables.
Adherence
Participants in the active treatment groups attended an average of 77 exercise sessions (mean
sessions = 77.5 (SD = 27.2)) and were exercising at or above their target heart range during
approximately 83% of their heart rate checks. Among participants completing the study,
participants in the EX group attended approximately 74.8% of exercise sessions and exercised
at or above their target heart rate during approximately 84.6% of their sessions. Participants in
the WM group attended an average of 78.7% of exercise sessions and exercised at or above
their target heart rate during approximately 81.2% of their sessions. There were no significant
differences between the EX and WM groups in attendance or adherence to the exercise
protocol, although younger participants tended to have lower attendance (p = .06). Adherence
to the exercise protocol was not associated with pretreatment levels of depressive symptoms
(p = .411).
Changes in Blood Pressure, Body Weight, and Aerobic Capacity
EX and WM groups showed significant reductions in systolic and diastolic blood pressures at
the completion of the study compared with control participants (F1,127 = 10.88, P < .001;
F1,127 = 29.46, p < .001), although there were no significant differences between the EX and
WM groups (F1,127 = 1.95, P = .165; F1,127 = 1.72, P < .192). There were significant differences
between the 3 groups in weight loss such that participants in the active treatment groups
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demonstrated significantly greater weight loss compared with control participants (F1,114 =
30.44, P < .001) and WM participants showed greater weight loss compared with their EX
counterparts (F1,114 = 48.68, P < .001). Participants in the EX and WM participants groups
lost an average of 1.8 and 7.9 kilograms (kgs) while control participants gained an average of .
71 kgs.
Participants in the active treatment groups also showed greater improvement in exercise
treadmill time (ETT) (F1,115 = 50.83, P < .001) and peak oxygen consumption (VO2) (F1,106
= 35.35, P < .001) compared with controls. In addition, WM participants experienced greater
improvements in ETT compared with EX participants (F1,115 = 14.68, P < .01), although the
groups did not differ significantly in VO2 improvement (F1,106 = 1.08, P = .30). Analysis of
pre-to-post treatment mean differences for treadmill time showed that EX and WM participants
increased their ETT by 77 and 136 seconds, respectively, while WLC participants showed a 8
second decline. Similarly, pre-to-post treatment mean gains for VO2 peak were .25 and .29
mL/kgs/min for EX and WM participants, whereas WLC participants exhibited a −.05 mL/
kgs/min decline.
Changes in depression
Participants exhibited low levels of depression at baseline (mean BDI = 4.8 (SD = 4.3)) and
only 21 participants (16%) reported at least “mild” levels of depression[39]. Planned contrasts
examining treatment effects on posttreatment depression showed no differences between the
EX and WM groups compared with the WLC group (F 1,112 = 0.92, p = .339). Similarly, the
EX and WM groups did not differ significantly (F 1,112 = 0.08, P = .773) in post-treatment
levels of depression.
Further analysis of treatment differences in depression revealed a significant treatment group
by baseline depression severity interaction (F2,106 = 5.75, P < .01) in predicting posttreatment
levels of depression, such that participants in the WM and EX groups with higher BDI scores
at baseline demonstrated significantly greater reductions in BDI scores compared with controls.
The reduction in depressive symptoms among participants in the active treatment groups was
more pronounced in the WM group, although EX participants also improved significantly
(Figure 2). In order to examine the magnitude of this effect, we examined the number of
participants who exhibited a > 25% reduction in BDI scores, consistent with previous clinical
investigations. Excluding those participants who reported no depressive symptoms at baseline,
and could therefore not improve (n = 19), approximately 35.4% of EX participants and 38.1%
of WM participants showed significant reductions in depressive symptoms, compared to only
21.7% of WLC participants.
Mediators of Change in Depressive Symptoms
In order to investigate potential mediators to the improvement in depressive symptoms, the
relationships between improvement in VO2 peak, weight loss, and depression were examined.
Analysis of changes in VO2 revealed a significant three-way interaction between baseline
depression severity, group assignment, and change in VO2 (F2,92 = 4.64, P = .01) such that
posttreatment levels of depression were related to increased aerobic fitness among participants
in the active treatment groups with elevated BDI scores at baseline. An analysis of raw change
scores in depression and aerobic capacity among this group of participants showed a significant
association between improvement in depression and increased VO2 peak (r = .36, P =.02),
indicating that reduced levels of depression were mediated by increases in aerobic capacity.
Neither weight loss, nor blood, pressure was associated with reduced levels of depression.
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Results from the present analysis demonstrate that for men and women with high blood pressure
and mild to moderate levels of depression, depressive symptoms may be reduced to a greater
extent by an exercise program, either alone or combined with a weight management
intervention, compared with participants receiving no treatment. Furthermore, among
participants in the active treatment groups, reduced levels of depression were associated with
increased aerobic capacity such that participants with greater improvements in VO2 peak
showed greater reductions in depression.
Our results are consistent with previous studies, which indicated that exercise can reduce
depressive symptoms in healthy individuals [15,16,40–42] as well as patients with conditions
such as heart disease [18–25,43] and arthritis [44]. Because both hypertension [28,29] and
elevated depressive symptoms [45,46] are independent risk factors for CHD, an exercise
intervention that reduces blood pressure and depression may be especially beneficial among
hypertensive patients, a group at elevated risk for the development of CHD.
We observed that the antidepressant effect of exercise was moderated by pretreatment levels
of depression. Participants with initially elevated levels of depressive symptoms benefited from
exercise, whereas exercise resulted in minimal changes in depression for participants who were
initially non-depressed. It is possible that there was a “floor effect” such that participants with
low depressive symptoms had no room for improvement, hence only those participants with
elevated depressive scores could improve. Alternatively, it is possible that, among individuals
with elevated levels of depressive symptoms at baseline, those whose depressive symptoms
were more rapidly reduced were able to engage in the exercise portion of the intervention more
effectively.
Exercise has repeatedly been shown to reduce depressive symptoms in a variety of depressed
populations[7] and to be equally effective[11] compared to anti-depressant therapy. In one of
the first clinical trials to evaluate the use of aerobic exercise as a treatment for major depressive
disorder (MDD), Blumenthal and colleagues [11] found that a 16-week aerobic exercise
intervention was equally effective to treatment with Sertraline in alleviating depressive
symptoms. Moreover, in a follow-up analysis from this original trial, Babyak and colleagues
[12] found individuals who participated in the exercise portion of the study were less likely to
have a recurrent depressive episode 10 months following study completion and that reduced
risk was associated with higher levels of physical activity in this subset of patients. Similarly,
in a recent meta-analysis of 11 treatment outcome studies utilizing physical activity in the
treatment of depression, Stathopoulou and colleagues [7] found a clear advantage of exercise
compared to control conditions.
Mechanisms by which exercise may reduce depressive symptoms by affecting changes in
central monoamines, increasing hypothalamic-pituitary-adrenal (HPA) axis regulation,
altering endorphin levels, increasing positive self-evaluations, and by enhancing
cardiopulmonary functioning. Improved aerobic capacity assessed by VO2 peak has been
associated with improvement in depression in several previous studies among both cardiac
patients [18,19,47] and healthy patients [48,49]. Recent studies have shown that decreased
aerobic capacity predicts increased levels of depressive symptoms as early as two weeks
following exercise withdrawal among healthy individuals [50]. Among individuals with
depression, Dunn and colleagues (CIT) recently demonstrated that a dose response relationship
may exist between increased levels of aerobic fitness and decreased levels of depression. Our
results provide further evidence to support this relationship by showing that training-induced
improvement in aerobic capacity was associated with a reduction in symptoms of depression.
These findings suggest that improved fitness may have contributed to the antidepressant effects
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of the exercise interventions. In contrast to previous findings [51], weight reduction was not
significantly associated with improvement in depression.
The findings of this study had several notable limitations. First, because participants exhibited
relatively low levels of depression at baseline our findings may not be generalizable to
individuals with more severe depressive symptoms. Second, because depressive symptoms
were assessed currently at two time points, the direction of the relationship was between
changes in depressive symptoms and changes in aerobic fitness is unclear: improved aerobic
capacity could result in reduced depression, or reduced depression may contribute to improved
aerobic capacity. Finally, the WLC group in our study did not receive as much attention from
the study staff as the active treatment groups, which may have affected their mood over the
course of the 6-month treatment program. Future studies investigating this relationship would
be improved with the addition of an attentional control group.
Results of this study may have important clinical implications. Previous studies have shown
that depression is associated with adverse medical outcomes [52]. Because depressive
symptoms have been associated with a greater incidence of adverse events in the presence of
hypertension [33,53], we feel that our findings may have important implications for the
management of depression among hypertensive individuals. Furthermore, given that
depression has been associated with a greater risk for both the development of CHD [54] and
increased mortality following cardiac events [55], interventions that alleviate depressive
symptoms in this at-risk population may have important public health implications. Future
research should examine the benefits of exercise on clinical outcomes among depressed
hypertensive patients, including assessment of other important biomarkers of risk.
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Table 1
Background characteristics*
Variable EX (n = 54) WM (n = 55) WLC (n = 24) Total (n = 133)
Age, mean (SD), y 46.6 (8.2) 48.5 (9.9) 47.2 (7.4) 47.5 (8.8)
Males 25 (46.3) 21 (38.2) 13 (54.2) 59 (44.4)
Caucasians 41 (75.9) 44 (80.0) 15 (62.5) 100 (75.2)
College Degree 38 (70.4) 34 (61.8) 15 (62.5) 87 (65.4)
SBP, mean (SD), mm Hg 141.1 (14.8) 145.5 (16.3) 145.7 (14.0) 143.7 (15.3)
DBP, mean (SD), mm Hg 91.0 (8.1) 90.6 (7.6) 91.5 (7.1) 90.9 (7.7)
Body weight, mean (SD), KGS 95.5 (14.5) 93.4 (16.9) 93.1 (16.9) 94.2 (15.9)
BDI, mean (SD) 5.2 (4.1) 4.0 (4.1) 5.7 (5.0) 4.8 (4.5)
*
Data are given as number (percentage) unless otherwise indicated. SBP indicates systolic blood pressure; DBP indicates diastolic blood pressure; mm
Hg indicates millimeters of mercury; KGS indicates kilograms; BDI indicates Beck Depression Inventory.
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